Zicam Cold Medication Effectiveness Class Action Settlement
Class Eligibility
The class is defined as all residents of the United States of America who purchased any of the following Zicam products in the United States from February 15, 2011 through June 5, 2018: RapidMelts Original, RapidMelts Ultra, Oral Mist, Ultra Crystals, Liqui-Lozenges, Lozenges Ultra, Soft Chews, Medicated Fruit Drops, and Chewables (the “Products”).
Estimated Amount
$6.16 – $11.53
Consumers may claim up to five products without proof of purchase
Proof of Purchase
No
Claim Form
Case Name
Melgar v. Zicam LLC et al.,
Case No. 2:14-cv-00160-MCE-AC
District Court for the Eastern District of California
Case Summary
A Proposed Settlement has been reached in a class action lawsuit in the United States District Court, Eastern District of California, (the “Action”) that may affect your rights. The Plaintiff claims that Zicam LLC and Matrixx Initiatives, Inc. (“Zicam”), made false and misleading statements about the effectiveness of certain Zicam products in violation of state and federal law. Zicam denies this claim. The Court has not ruled in favor of Plaintiff or Zicam. Instead, the parties agreed to a Proposed Settlement to avoid the expense and risks of continuing the lawsuit.
Settlement Pool
$16,000,000
Settlement Website
Deadline
10/3/2018
Contact
Zicam Class Action
c/o RG/2 Claims Administration
P.O. Box 59479
Philadelphia, PA 19102-9479
info@rg2claims.com
(855) 279-8685
